These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1968961)

  • 1. Formation of [Leu5]enkephalin from dynorphin A(1-8) by rat central nervous tissue in vitro.
    Dixon DM; Traynor JR
    J Neurochem; 1990 Apr; 54(4):1379-85. PubMed ID: 1968961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that the agonist action of dynorphin A(1-8) in the guinea-pig myenteric-plexus may be mediated partly through conversion to [Leu5]enkephalin.
    Dixon DM; Traynor JR
    Br J Pharmacol; 1990 Nov; 101(3):674-8. PubMed ID: 1981690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enkephalin is liberated from metorphamide and dynorphin A1-8 by endo-oligopeptidase A, but not by metalloendopeptidase EC 3.4.24.15.
    Toffoletto O; Metters KM; Oliveira EB; Camargo AC; Rossier J
    Biochem J; 1988 May; 252(1):35-8. PubMed ID: 2901829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synaptosomal membrane-bound form of endopeptidase-24.15 generates Leu-enkephalin from dynorphin1-8, alpha- and beta-neoendorphin, and Met-enkephalin from Met-enkephalin-Arg6-Gly7-Leu8.
    Acker GR; Molineaux C; Orlowski M
    J Neurochem; 1987 Jan; 48(1):284-92. PubMed ID: 2878974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conversion of dynorphin A(1-8) to [Leu5]-enkephalin in rat central nervous tissue during development.
    Dixon DM; Traynor JR
    Neuropeptides; 1993 Aug; 25(2):121-5. PubMed ID: 8105413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion of dynorphin-(1-9) to [Leu5]enkephalin by the mouse vas deferens in vitro.
    Miller L; Rance MJ; Shaw JS; Traynor JR
    Eur J Pharmacol; 1985 Oct; 116(1-2):159-63. PubMed ID: 2865158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain endo-oligopeptidase A, a putative enkephalin converting enzyme.
    Camargo AC; Oliveira EB; Toffoletto O; Metters KM; Rossier J
    J Neurochem; 1987 Apr; 48(4):1258-63. PubMed ID: 2880931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Degradation of dynorphin-(1-13) and dynorphin-(1-17) by the neuroblastoma cell membrane. Evidence for the involvement of a cysteine protease.
    Satoh M; Yokosawa H; Ishii S
    Biochem Biophys Res Commun; 1986 Oct; 140(1):335-41. PubMed ID: 2877660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of dynorphin-converting enzymes prolongs the antinociceptive effect of intrathecally administered dynorphin in the mouse formalin test.
    Tan-No K; Taira A; Sakurada T; Inoue M; Sakurada S; Tadano T; Sato T; Sakurada C; Nylander I; Silberring J; Terenius L; Kisara K
    Eur J Pharmacol; 1996 Oct; 314(1-2):61-7. PubMed ID: 8957219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative structure-function studies with analogs of dynorphin-(1-13) and [Leu5]enkephalin.
    Schiller PW; Eggimann B; Nguyen TM
    Life Sci; 1982 Oct 18-25; 31(16-17):1777-80. PubMed ID: 6130438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of kelatorphan and other peptidase inhibitors on the in vitro and in vivo release of methionine-enkephalin-like material from the rat spinal cord.
    Bourgoin S; Le Bars D; Artaud F; Clot AM; Bouboutou R; Fournie-Zaluski MC; Roques BP; Hamon M; Cesselin F
    J Pharmacol Exp Ther; 1986 Jul; 238(1):360-6. PubMed ID: 3459871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of opioid peptides containing the sequence of Met5-enkephalin or Leu5-enkephalin on nicotine-induced secretion from bovine adrenal chromaffin cells.
    Marley PD; Mitchelhill KI; Livett BG
    J Neurochem; 1986 Jan; 46(1):1-11. PubMed ID: 2866231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kappa-binding and degradation of [3H]dynorphin A (1-8) and [3H]dynorphin A (1-9) in suspensions of guinea pig brain membranes.
    Gillan MG; Robson LE; McKnight AT; Kosterlitz HW
    J Neurochem; 1985 Oct; 45(4):1034-42. PubMed ID: 2863329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of a dynorphin A (1-8) degrading enzyme from the spinal cord by intraventricular morphine in the rat.
    Tseng LF
    Life Sci; 1988; 42(13):1287-93. PubMed ID: 2451104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynorphin-(1-13): the effect of in vivo treatment on opiate bindings in vitro.
    Jen MF; Garzon J; Loh HH; Lee NM
    Eur J Pharmacol; 1983 Jul; 91(1):95-9. PubMed ID: 6311575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Release of [Leu5]enkephalin immunoreactivity from the isolated perfused rat stomach.
    Nishimura E; McIntosh CH
    Eur J Pharmacol; 1986 May; 124(1-2):43-9. PubMed ID: 3720843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of immunoreactive Met-enkephalin from the spinal cord by intraventricular beta-endorphin but not morphine in anesthetized rats.
    Tseng LF; Higgins MJ; Hong JS; Hudson PM; Fujimoto JM
    Brain Res; 1985 Sep; 343(1):60-9. PubMed ID: 2864105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynorphin levels in parkinsonian patients: Leu5-enkephalin production from either proenkephalin A or prodynorphin in human brain.
    Taquet H; Javoy-Agid F; Giraud P; Legrand JC; Agid Y; Cesselin F
    Brain Res; 1985 Aug; 341(2):390-2. PubMed ID: 2864101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [3H]-dynorphin A (1-9): binding characteristics and degradation profile in brain homogenates.
    Robson LE; Gillan MG; McKnight AT; Kosterlitz HW
    Life Sci; 1983; 33 Suppl 1():283-6. PubMed ID: 6319878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [3H]-Dynorphin A (1-8): degradation profile and binding characteristics in brain homogenates.
    Gillan MG; Robson LE; McKnight AT; Kosterlitz HW
    Neuropeptides; 1985 Feb; 5(4-6):533-6. PubMed ID: 2860610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.